Table 1S. Model quality parameters for Figure 1 PLS-DA models.
Mode | R2X (cum) | R2Y (cum) | Q2Y (cum) | Intercept |
|
R2 | Q2 | ||||
Peripheral venous blood of HF patients vs. healthy controls | |||||
HILIC/ESI+ | 0.207 | 0.958 | 0.862 | 0.815 | –0.104 |
HILIC/ESI− | 0.185 | 0.976 | 0.877 | 0.845 | –0.122 |
RPLC/ESI+ | 0.187 | 0.972 | 0.789 | 0.853 | –0.029 |
RPLC/ESI− | 0.0944 | 0.883 | 0.747 | 0.663 | –0.159 |
Peripheral venous blood of CRT responders vs. non-responders | |||||
HILIC/ESI+ | 0.128 | 0.941 | –0.207 | 0.906 | 0.127 |
HILIC/ESI− | 0.0806 | 0.752 | 0.0412 | 0.685 | –0.0183 |
RPLC/ESI+ | 0.128 | 0.969 | 0.224 | 0.967 | –0.0179 |
RPLC/ESI− | 0.0616 | 0.863 | 0.02 | 0.79 | –0.0355 |
Coronary sinus blood of CRT responders vs. non-responders | |||||
HILIC/ESI+ | 0.138 | 0.907 | –0.171 | 0.884 | 0.0396 |
HILIC/ESI− | 0.0756 | 0.685 | –0.1 | 0.666 | –0.00184 |
RPLC/ESI+ | 0.144 | 0.948 | 0.0478 | 0.946 | –0.00651 |
RPLC/ESI− | 0.142 | 0.965 | 0.208 | 0.957 | 0.316 |